CrossRef Editorial: Time to GenotypeGenetic Risk and Prognosis in Steatotic Liver Disease Rosellina M
To help ensure you reach your goals, consider incorporating these healthy habits into your daily routine: Take your medication as directed, support your progress with nutritious meals, engage in consistent, moderate physical activity
These stories serve as motivation for anyone facing similar challenges, showing that with the right help and commitment, meaningful change is within reach
Genetically predicted glucose-dependent Insulinotropic polypeptide (GIP) levels and Cardiovascular Disease Risk are driven by distinct causal variants in the GIPR Region
Additionally, a recent real-world study reported greater weight loss with tirzepatide than with semaglutide in overweight or obese patients [7], which further supports the trends noted in our study
Whether that balance holds across long-term use in diverse patients is exactly what the phase 3 program is designed to answer
